Linking genotype with phenotype in inflammatory bowel disease--Will we ever have reagent standard patients?
Ghosh
S
S
Gastrointestinal Unit, Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, Scotland, UK. sg@srv0.med.ed.ac.uk
D015209:Cholangitis, Sclerosing / Q000453:epidemiology; D003093:Colitis, Ulcerative / Q000453:epidemiology / Q000235:genetics; D015897:Comorbidity; D003424:Crohn Disease / Q000453:epidemiology / Q000235:genetics; D016207:Cytokines / Q000235:genetics; D004777:Environment; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D008954:Models, Biological; D010641:Phenotype; D011110:Polymorphism, Genetic; D017027:Protein Tyrosine Phosphatases / Q000235:genetics; D015203:Reproducibility of Results; D017678:Sex Distribution; D013167:Spondylitis, Ankylosing / Q000453:epidemiology
D016207:Cytokines; D017027:Protein Tyrosine Phosphatases